Method for mounting and finishing valve seat rings pre-manufactured by
powder metallurgical method techniques
    1.
    发明授权
    Method for mounting and finishing valve seat rings pre-manufactured by powder metallurgical method techniques 失效
    通过粉末冶金方法技术预先制造的安装和修整阀座环的方法

    公开(公告)号:US5735043A

    公开(公告)日:1998-04-07

    申请号:US623488

    申请日:1996-03-28

    IPC分类号: B22F7/06 F01L3/22 B23P11/00

    摘要: In a method for mounting and finishing a valve seat ring in an operational position of a receiving bore at the entrance of a gas channel of the cylinder head of an internal combustion engine consisting of a light alloy, an annular body with a central opening is manufactured by powder pressing and sintering. A roller burnishing tool is positioned within the central of the annular body. The annular body is inserted into the receiving bore with the aid of the roller burnishing tool such that the annular body is positioned with play relative the inner wall of the receiving bore. The annular body is radially expanded by roller burnishing with the roller burnishing tool such that the annular body positive-lockingly engages the inner wall of the receiving bore and is compressed to a selected finish size of ready-to-use density.

    摘要翻译: 在用于在由轻合金构成的内燃机的气缸盖的气体通道的入口处的接收孔的操作位置安装和修整阀座环的方法中,制造具有中心开口的环形体 通过粉末压制和烧结。 辊抛光工具位于环形体的中心内。 借助于滚筒抛光工具将环形体插入接收孔中,使得环形体相对于容纳孔的内壁定位成游隙。 环形体通过滚筒抛光工具通过滚筒抛光而径向膨胀,使得环形体正向锁定地接合接收孔的内壁并被压缩成所选择的即用型密度的精加工尺寸。

    Benzazepine derivatives, their pharmaceutical compositions and method of
use
    2.
    发明授权
    Benzazepine derivatives, their pharmaceutical compositions and method of use 失效
    苯扎西平衍生物,其药物组合物和使用方法

    公开(公告)号:US4490369A

    公开(公告)日:1984-12-25

    申请号:US547940

    申请日:1983-11-02

    摘要: Compounds of the formula ##STR1## wherein A is --CH.sub.2 --CH.sub.2 --, --CH.dbd.CH--, --NH--CO--, --CH.sub.2 --CO-- or ##STR2## where R.sub.7 is alkyl of 1 to 3 carbon atoms, andB is methylene, carbonyl or thiocarbonyl, orA is --CO--CO--, --N.dbd.CH--, ##STR3## where R.sub.8 is hydrogen or alkyl of 1 to 3 carbon atoms substituted by a phenyl, methoxyphenyl or dimethoxyphenyl, andB is methylene;E is n-alkylene of 2 to 4 carbon atoms optionally substituted by an alkyl of 1 to 3 carbon atoms, 2-hydroxy-n-propylene, 2-hydroxy-n-butylene or 3-hydroxy-n-butylene;G is n-alkylene of 1 to 5 carbon atoms optionally substituted by an alkyl of 1 to 3 carbon atoms, wherein one methylene group of an n-alkylene of 2 to 5 carbon atoms can be replaced by a carbonyl group, with the proviso that B represents a methylene or carbonyl group, or methylene-n-hydroxy-alkylene of 1 to 4 carbon atoms, where the methylene group is attached to the nitrogen atom; andR.sub.1 to R.sub.5 are simple substituents of various types;and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.

    摘要翻译: 其中A是-CH 2 -CH 2 - , - CH = CH - , - NH-CO-, - CH 2 -CO-或者其中R 7是1至3个碳原子的烷基,和B 是亚甲基,羰基或硫代羰基,或A是-CO-CO-,-N = CH-,其中R 8是氢或被苯基,甲氧基苯基或二甲氧基苯基取代的1至3个碳原子的烷基,和 B是亚甲基; E是任选被1至3个碳原子的烷基取代的2至4个碳原子的正亚烷基,2-羟基 - 正丙烯,2-羟基 - 正丁烯或3-羟基 - 正丁烯; G是任选被1至3个碳原子的烷基取代的1至5个碳原子的正亚烷基,其中2至5个碳原子的正亚烷基的一个亚甲基可被羰基取代,条件是 B表示亚甲基或羰基,或亚甲基与氮原子连接的1至4个碳原子的亚甲基 - 正 - 羟基 - 亚烷基; 而R1至R5是各种简单的取代基; 和无毒的,药学上可接受的酸加成盐。 化合物及其盐可用作心动过缓。

    Amino-benzoic acid amides
    3.
    发明授权
    Amino-benzoic acid amides 失效
    氨基 - 苯甲酸酰胺

    公开(公告)号:US4093734A

    公开(公告)日:1978-06-06

    申请号:US734818

    申请日:1976-10-22

    摘要: Compounds of the formula ##STR1## wherein (A) WHEN THE AMINO-SUBSTITUENT IS IN THE P-POSITION WITH RESPECT TO THE CARBONYL GROUP,R.sub.1 is chlorine in the o-position with respect to the carbonyl group,R.sub.2 is hydrogen, andR.sub.3 is ethylamino, cyclopentylamino, cyclohexylamino, cycloheptylamino, N-methyl-cyclohexylamino, benzylamino or 1-ethyl-pyrrolidyl-(2)-aminomethyl, or(b) when the amino-substituent is in the o--, m-- or p-position with respect to the carbonyl group,R.sub.1 is hydrogen, chlorine or bromine,R.sub.2 is trifluoromethyl, nitro or, when R.sub.4 is 1-(alkyl of 1 to 3 carbon atoms)-pyrrolidyl or 1-(alkyl of 1 to 3 carbon atoms)-piperidyl, also fluorine, chlorine, bromine or methyl,R.sub.3 is (alkyl of 1 to 5 carbon atoms)-amino, (cycloalkyl of 3 to 7 carbon atoms)-amino, benzylamino, quinuclidinyl-amino or --NH--(CH.sub.2).sub.n --R.sub.4where R.sub.4 is pyridyl, 1-(alkyl of 1 to 3 carbon atoms)-pyrrolidyl, 1-(alkyl of 1 to 3 carbon atoms)-piperidyl or, when n is 2 or 3, also imidazolonyl, pyrrolidino, piperidino or morpholino, andn is 0, 1, 2 or 3,And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as anxiolytics, anticonvulsives, antiemetics and antiulcerogenics.

    摘要翻译: 式(A)的化合物其中(A)当氨基取代基位于与碳组相对位置时,R 1为相对于羰基的o位置的氯,R 2为氢,R 3为 是乙基氨基,环戊基氨基,环己基氨基,环庚基氨基,N-甲基 - 环己基氨基,苄基氨基或1-乙基 - 吡咯烷基 - (2) - 氨基甲基,或(B)当氨基取代基位于O-, 对于羰基,R1是氢,氯或溴,R2是三氟甲基,硝基,或当R4是1-(1至3个碳原子的烷基) - 吡咯烷基或1-(1至3个碳原子的烷基)时, - 哌啶基,氟,氯,溴或甲基,R3是(碳原子数1〜5的烷基) - 氨基,(3〜7个碳原子的环烷基) - 氨基,苄基氨基,奎宁环基 - 氨基或-NH-(CH2) n-R4,其中R4是吡啶基,1-(1至3个碳原子的烷基) - 吡咯烷基,1-(1至3个碳原子的烷基) - 哌啶基,或当n是2或3时,也是咪唑啉基,吡咯烷子基,哌啶子基 或mor pholino和N IS 0,1,2或3,以及非毒性,药理学上可接受的酸添加量; 化合物作为它们的有效的有用的ANXIOLYTICS,ANTICONVULSIVES,抗原和抗生素。

    Halo-substituted hydroxybenzyl-amines as secretolytic agents
    4.
    发明授权
    Halo-substituted hydroxybenzyl-amines as secretolytic agents 失效
    卤代取代的羟基苄基胺作为分泌溶剂

    公开(公告)号:US4073942A

    公开(公告)日:1978-02-14

    申请号:US635220

    申请日:1975-11-25

    IPC分类号: A61K31/135 C07C87/29

    摘要: Compounds of the formula ##STR1## wherein X is chlorine or bromine;R.sub.1 is hydrogen, chlorine or bromine;R.sub.2 is isopropyl; tert.butyl; tert.pentyl; mono-, di- or tri-hydroxy-substituted branched alkyl of 3 to 5 carbon atoms; cyclohexyl; or hydroxycyclohexyl; andR.sub.3 is alkyl of 1 to 4 carbon atoms or, when R.sub.2 is other than cyclohexyl, also hydrogen;And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as secretolytics, antitussives, anti-ulcerogenics and stimulants for the production of the surfactant or anti-atelectasis factor of the alveoli.

    摘要翻译: 其中X是氯或溴的式“IMAGE”的化合物; R1是氢,氯或溴; R2是异丙基; 叔丁基 叔戊基 3至5个碳原子的单,二或三羟基取代的支链烷基; 环己基 或羟基环己基; 并且R 3是1至4个碳原子的烷基,或者当R 2不是环己基时,也是氢; 和非毒性,药理学上可接受的酸添加量; 该化合物作为其生物利用作为秘密,抗生素,抗生素和抗生素用于生产ALVEOLI的表面活性剂或抗原决定因子。

    Antiphlogistic pharmaceutical compositions containing a
phenylethanolamine and methods of use
    5.
    发明授权
    Antiphlogistic pharmaceutical compositions containing a phenylethanolamine and methods of use 失效
    含有苯乙醇胺的消炎药物组合物及其使用方法

    公开(公告)号:US4244967A

    公开(公告)日:1981-01-13

    申请号:US72553

    申请日:1979-09-04

    摘要: The method of using compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, fluorine, chlorine, bromine, iodine or cyano,R.sub.2 is fluorine, cyano, trifluoromethyl, nitro or alkyl of 1 to 4 carbon atoms,R.sub.3 is cycloalkyl or alkyl, each of 3 to 5 carbon atoms, andR.sub.4 is hydrogen or --CO--R.sub.5, whereR.sub.5 is alkoxy of 1 to 5 carbon atoms, alkenyloxy of 2 to 5 carbon atoms, aryloxy of 6 to 10 carbon atoms, aralkoxy of 7 to 11 carbon atoms, or amino which may be mono- or di-substituted by alkyl of 1 to 5 carbon atoms, alkenyl of 2 to 5 carbon atoms, aryl of 6 to 10 carbon atoms and/or aralkyl of 7 to 11 carbon atoms,and non-toxic, pharmacologically acceptable acid addition salts thereof as antirheumatics and antiphlogistics.

    摘要翻译: 使用下式化合物的方法其中R1是氢,氟,氯,溴,碘或氰基,R2是氟,氰基,三氟甲基,硝基或1-4个碳原子的烷基,R3是环烷基或烷基, 3〜5个碳原子,R4为氢或-CO-R5,R5为1〜5个碳原子的烷氧基,2〜5个碳原子的烯氧基,6〜10个碳原子的芳氧基,7〜11个芳氧基 碳原子或可以被1至5个碳原子的烷基,2至5个碳原子的烯基,6至10个碳原子的芳基和/或7至11个碳原子的芳烷基单取代或二取代的氨基,以及 无毒,药理学上可接受的酸加成盐作为抗风湿剂和消炎药。

    2- OR 4-Hydroxy-3,5-dihalo-benzylamines and salts thereof
    6.
    发明授权
    2- OR 4-Hydroxy-3,5-dihalo-benzylamines and salts thereof 失效
    2-或4-羟基-3,5-二卤代苄胺及其盐

    公开(公告)号:US4113777A

    公开(公告)日:1978-09-12

    申请号:US812325

    申请日:1977-07-01

    IPC分类号: A61K31/135 C07C87/28

    摘要: Compounds of the formula ##STR1## wherein X and R.sub.1 are each chlorine or bromine;R.sub.2 is isopropyl; tert.butyl; tert.pentyl; mono-, di- or tri-hydroxy-substituted branched alkyl of 3 to 5 carbon atoms; cyclohexyl; or hydroxycyclohexyl; andR.sub.3 is alkyl of 1 to 4 carbon atoms or, when R.sub.2 is other than cyclohexyl, also hydrogen;And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as secretolytics, antitussives, anti-ulcerogenics and stimulants for the production of the surfactant or antiatelectasis factor of the alveoli.

    摘要翻译: 其中X和R 1各自为氯或溴的式“IMAGE”的化合物; R2是异丙基; 叔丁基 叔戊基 3至5个碳原子的单,二或三羟基取代的支链烷基; 环己基 或羟基环己基; 并且R 3是1至4个碳原子的烷基,或者当R 2不是环己基时,也是氢; 和非毒性,药理学上可接受的酸添加量; 化合物作为其生物利用作为秘密,抗生素,抗生素和抗生素用于生产ALVEOLI的表面活性剂或抗原决定因子。

    Pharmaceutical compositions containing an aminobenzyl-amine and method
of use
    7.
    发明授权
    Pharmaceutical compositions containing an aminobenzyl-amine and method of use 失效
    含氨基苄基胺的药物组合物及其使用方法

    公开(公告)号:US4006246A

    公开(公告)日:1977-02-01

    申请号:US649481

    申请日:1976-01-15

    CPC分类号: A61K31/19 A61K31/135

    摘要: Pharmaceutical dosage unit compositions containing as an active ingredient a compound of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkanoyl, benzoyl or halobenzoyl,R.sub.2 is hydrogen, chlorine or bromine,R.sub.3 is carboxyl or lower carbalkoxy, andR.sub.4 and R.sub.5 are each hydrogen, alkyl of 1 to 5 carbon atoms, mono- or di-hydroxy-(alkyl of 1 to 5 carbon atoms), alkenyl or 2 to 4 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, mono- or di-hydroxy-(cycloalkyl of 5 to 7 carbon atoms) or benzyl,Or a non-toxic, pharmacologically acceptable acid addition salt thereof; and a method of using the same as anti-ulcerogenics, secretolytics, antitussives, and stimulants of the production of the surfactant or antiatelectasis factor of the alveoli.

    摘要翻译: 含有下式化合物作为活性成分的药物剂量单位组合物,其中R 1是氢,低级烷酰基,苯甲酰基或卤代苯甲酰基,R 2是氢,氯或溴,R 3是羧基或低级烷氧羰基,R 4和R 5各自是 氢,1至5个碳原子的烷基,一或二羟基 - (1至5个碳原子的烷基),烯基或2至4个碳原子,5至7个碳原子的环烷基,一或二羟基 - (5至7个碳原子的环烷基)或苄基,或非毒性,药理学上可接受的酸添加盐; 以及使用它们作为抗生素,秘密,抗生素和生物活性物质的抗生素或抗原决定因子的方法。

    Process for producing cylinder heads for internal combustion engines
    8.
    发明授权
    Process for producing cylinder heads for internal combustion engines 失效
    生产内燃机缸盖的工艺

    公开(公告)号:US6112803A

    公开(公告)日:2000-09-05

    申请号:US155382

    申请日:1998-09-28

    申请人: Gerd Kruger

    发明人: Gerd Kruger

    CPC分类号: F01L3/08 B22D19/0009 F01L3/22

    摘要: The cylinder head for internal combustion engines is produced by pouring liquid cylinder head material, especially aluminum, into a cylinder head mold containing a mold core having stepped sections in the region of the valve seat ring and the valve guide. The valve seat rings and valve guides are produced from a conventional material based on steel or copper by pressing and sintering in such a way that they have an open pore volume of 5 to 15%, a valve seat and/or a valve guide are laid on the stepped sections of the mold core, whereafter liquid aluminum is poured into the preheated mold and the mold core is removed in the conventional way after the molten aluminum has solidified.

    摘要翻译: PCT No.PCT / EP97 / 01540 Sec。 371日期:1998年9月28日 102(e)日期1998年9月28日PCT 1997年3月26日PCT公布。 出版物WO97 / 37107 日期1997年10月9日内燃机气缸盖通过将液压缸头材料(特别是铝)倒入气缸盖模具中而制成,该气缸盖模具包含在阀座环和阀导向件区域中具有阶梯部分的模芯。 阀座环和阀导轨由常规的基于钢或铜的材料通过压制和烧结制成,使得它们具有5至15%的开孔容积,阀座和/或阀导轨被铺设 在模芯的阶梯部分上,然后将液态铝注入预热的模具中,并且在熔融铝固化后以常规方式去除模芯。

    Substituted bis-(4-aminophenyl)-sulfones
    9.
    发明授权
    Substituted bis-(4-aminophenyl)-sulfones 失效
    取代的双 - (4-氨基苯基) - 砜

    公开(公告)号:US4829058A

    公开(公告)日:1989-05-09

    申请号:US62291

    申请日:1987-06-15

    摘要: Disclosed are substituted bis(4-aminophenyl)-sulfones of general formula ##STR1## wherein R.sub.1 is hydrogen, alkyl or cycloalkyl; group,R.sub.2 is hydrogen or C.sub.1 -C.sub.3 alkyl,R.sub.3 is nitrile, C.sub.1 -C.sub.3 alkylaminocarbonyl, di C.sub.1 -C.sub.3 alkylaminocarbonyl, C.sub.3 -C.sub.7 N-cycloalkyl-C.sub.1 -C.sub.3 alkylaminocarbonyl C.sub.1 -C.sub.3 alkylamino, C.sub.1 -C.sub.3, di alkylaminocarbonyl alkoxy, alkylaminosulfonyl, di C.sub.1 -C.sub.3 alkylaminono, diC.sub.1 -C.sub.3 alkylaminosulfonyl, hydroxy C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkylcarbonyl, amino C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy C.sub.1 -C.sub.3 alkyl groupor, when R.sub.1 and R.sub.2 are each hydrogen, R.sub.3 can be hydroxy, hydroxycarbonyl C.sub.1 -C.sub.3 alkoxy or di C.sub.1 -C.sub.3 aminocarbonylalkoxy;or, when R.sub.1 is C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 cycloalkyl and R.sub.2 is hydrogen or C.sub.1 -C.sub.3 alkyl, R.sub.3 can also be halogen, trifluoromethyl, nitro, amino, aminosulfonyl, aminocarbonyl, C.sub.1 -C.sub.3 alkyl, carboxy or C.sub.1 -C.sub.3 alkoxycarbonyl; andR.sub.4 is hydrogen or, when R.sub.1 and R.sub.2 are each hydrogen and R.sub.3 is halogen or hydroxy, R.sub.4 can also be halogen, hydroxy or C.sub.1 -C.sub.3 alkoxy; or a nontoxic, pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions comprising such compounds alone and in combination with dihydrofolic acid-reductase inhibitors. The compounds and compositions are useful for their inhibiting effect on bacteria, mycobacteria and plasmodia.

    摘要翻译: 公开了通式为(I)的取代的双(4-氨基苯基) - 砜,其中R 1是氢,烷基或环烷基; 基团,R 2是氢或C 1 -C 3烷基,R 3是腈,C 1 -C 3烷基氨基羰基,C 2 -C 3烷基氨基羰基,C 3 -C 7 N-环烷基-C 1 -C 3烷基氨基羰基C 1 -C 3烷基氨基,C 1 -C 3,二烷基氨基羰基烷氧基, 烷基氨基磺酰基,二C1-C3烷基氨基亚氨基,二C1-C3烷基氨基磺酰基,羟基C1-C3烷基,C1-C3烷基羰基,氨基C1-C3烷基或C1-C3烷氧基C1-C3烷基,或当R1和R2各自为氢时,R3 可以是羟基,羟基羰基C1-C3烷氧基或二C1-C3氨基羰基烷氧基; 或者当R1是C1-C3烷基或C1-C3环烷基,R2是氢或C1-C3烷基时,R3也可以是卤素,三氟甲基,硝基,氨基,氨基磺酰基,氨基羰基,C1-C3烷基,羧基或C1-C3 烷氧基羰基 并且R 4是氢,或者当R 1和R 2各自为氢且R 3为卤素或羟基时,R 4也可以是卤素,羟基或C 1 -C 3烷氧基; 或其无毒的药学上可接受的盐。 还公开了单独包含这些化合物并与二氢叶酸还原酶抑制剂组合的药物组合物。 化合物和组合物可用于其对细菌,分枝杆菌和疟原虫的抑制作用。